Naganathan Girish
SEC CIK 1949138 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| DXCM | Dexcom | EVP CTO | 47.7K | — | $254.2K | 3 | 2022-11-08 | 2023-11-09 |
Most active insiders at DXCM, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | SAYER KEVIN R | Executive COB, Dir | — | $8.30M |
| 2 | Leach Jacob Steven | Pres, COO | $1.00M | — |
| 3 | Brown Michael Jon | EVP, CLO | — | $873.4K |
| 4 | Coleman Jon | EVP, Chief Commercial Off | — | $722.6K |
| 5 | AUGUSTINOS NICHOLAS | Dir | — | $679.8K |
| 6 | FOLETTA MARK G | Dir | — | $627.2K |
| 7 | Collins Richard Alexander | Dir | — | $389.4K |
| 8 | Sylvain Jereme M | EVP, Chief Financal Off | — | $302.9K |
| 9 | Heller Bridgette P | Dir | — | $277.7K |
| 10 | Stern Sadie | EVP, Chief HR Off | — | $226.7K |
Naganathan Girish made no open-market trades at DXCM in the last 12 months.
Transactions 3
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2023-11-27 | 2023-11-09 | DXCM | Dexcom | Naganathan Girish | EVP CTO | S - Sale | $93.27 | -2,725 | 47.7K | -5% | -$254.2K | |
| 2023-03-10 | 2023-03-08 | DXCM | Dexcom | Naganathan Girish | EVP CTO | A - Grant | $0.00 | +18.8K | 50.2K | +60% | $0 | |
| 2022-11-14 | 2022-11-08 | DXCM | Dexcom | Naganathan Girish | EVP CTO | A - Grant | $0.00 | +31.4K | 31.4K | New | $0 |
Purchase Sale Sale after option exercise All abbreviations